We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DDOG:NASDAQDatadog, Inc. Analysis

Data as of 2026-09-05 - not real-time

$212.93

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Datadog, Inc. is neutral at $212.93, with no clear ordering between short and long averages. Over a rolling month the price has lost 13.7%. With RSI at 38.7 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $208.22 and resistance around $262.99.
Multiples put this in overvalued territory: 434.6 times earnings against the sector's 33.2. The average analyst target implies 33.9% above today's level. Revenue is growing at 35.6% on a 4.5% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 87.7%, a beta of 1.19 and a maximum drawdown of 48.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

David Moadel Wed, September 2, 2026 at 7:10 PM UTC 0 SuPatMaN / Shutterstock.Datadog Inc. DDOG shares are trading higher Thursday on possible continued momentum after strong earnings from...Datadog Inc DDOG delivers strong Q2 2026 results with record billings and RPO, while navigating a deliberate de-risking...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading above the 200-day average of 176.37
  • MACD momentum is negative
  • 30-day price change of -13.7%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 434.6 versus sector average of 33.2
  • Trading above the 200-day average of 176.37
  • Analyst targets imply +33.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 434.6 versus sector average of 33.2
  • Analyst targets imply +33.9% versus the current price
  • Revenue growth of +35.6%

Key Metrics & Analysis

Financial Health

Revenue Growth35.60%
Profit Margin4.48%
P/E Ratio434.6
ROE4.70%
ROA0.18%
Debt/Equity29.26
P/B Ratio17.5
Op. Cash Flow$1.2B
Free Cash Flow$1.1B
Industry P/E33.2

Technical Analysis

TrendNeutral
RSI38.7
Support$208.22
Resistance$262.99
MA 20$235.27
MA 50$249.23
MA 200$176.37
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$111.36
Target Price$285.18
Upside/Downside33.93%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.19
Volatility87.70%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.